$0.0950
At close: Mar 3, 3:16 PM EDT
Comments
Loading...
VentriPoint Diagnostics Analyst Ratings and Price Targets | OTC:VPTDF | Benzinga
VentriPoint Diagnostics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for VentriPoint Diagnostics Corp from these most-recent analyst ratings.
Analyst Ratings for VentriPoint Diagnostics
Data brought to you by Benzinga APIs
FAQ
What is the target price for VentriPoint Diagnostics (VPTDF) stock?
There is no price target for VentriPoint Diagnostics
What is the most recent analyst rating for VentriPoint Diagnostics (VPTDF)?
There is no analyst for VentriPoint Diagnostics
When was the last upgrade for VentriPoint Diagnostics (VPTDF)?
There is no last upgrade for VentriPoint Diagnostics
When was the last downgrade for VentriPoint Diagnostics (VPTDF)?
There is no last downgrade for VentriPoint Diagnostics.
When is the next analyst rating going to be posted or updated for VentriPoint Diagnostics (VPTDF)?
There is no next analyst rating for VentriPoint Diagnostics.
Is the Analyst Rating VentriPoint Diagnostics (VPTDF) correct?
There is no next analyst rating for VentriPoint Diagnostics.
Browse analyst ratings and price targets on all stocks.